China regulator confesses invalid tests; GE recalls dangerous ventilators; Pfizer recalls cough syrup;

> The FDA says Pfizer ($PFE) is voluntarily recalling its Robitussin DM cough syrup because of dosing inaccuracies for children. Story

> The FDA has assigned its most serious designation to GE Healthcare's ($GE) recall of Aestiva/5 7900, warning that a flaw in the devices could lead to circulatory shock and death. Story

> The FDA smacked Siemens Healthcare with the second warning letter in a month concerning quality and manufacturing issues with some of its diagnostics products. Story

> An FDA 483 inspection of Exemplar Pharmaceuticals of Fall River, MA, found the aerosol drugmaker lacked adequate controls to ensure consistent mixtures of its products. FDA report

And Finally... A Chinese agency acknowledged that invalid testing led it to say that vanillin had been found in baby formula from companies including Mead Johnson. Story

Suggested Articles

Pfizer says two lots of migraine med Relpax failed to meet microbial standards and may be contaminated with genera pseudomonas and burkholderia.

Emcure has had its share of run-ins with the FDA in the past over the sterility of its plants. Now, it can notch one more black mark on its belt.

The FDA has slapped a warning letter on an Indian solvent recycler that may have contributed to the contamination of blood pressure meds.